Tax Reg: 105-87-87282 | Diane joined Illumina in 2019 to support the global operations and administrative processes of Illumina Accelerator. for Illumina Cancer Hotspot Panel v2, AmpliSeq And to ensure we can make a meaningful difference, we focus our efforts on genomic literacy through STEM education, rare and undiagnosed genetic diseases, oncology, and community service. Courtney studied transgenic mice and patient samples to identify genes involved in autism and computationally investigated alternative splicing, HPV detection, and microRNA diversity. In addition, Dowdy played a pivotal role as a senior leader with the launch of the NovaSeq. Founded in Fall 2014 in San Francisco, Illumina She led process integration for the launch of phasing and long reads sequencing services for FastTrack and supported the scale-up of whole genome sequencing. Target Identification & Pathway Analysis, TruSeq Myriad Genetics, Inc. MYGN recently announced its entry into a strategic collaboration with Illumina, Inc. ILMN for improved outcomes in oncology. Cancer Target Identification with High-Throughput NGS, NGS of Rare & Undiagnosed Diseases, Cellular & Molecular Since joining Illumina in August 2016, Dowdy has reorganized the business, identified new markets and returned the region to sustainable growth. Table Illumina Product benchmarking. DNA Technology for NIPT, NIPT vs Traditional Aneuploidy Screening Methods, SNP © 2021 Illumina, Inc. All rights reserved. Let us know how we can help! Multidrug-Resistant Tuberculosis Strains, Investigating It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. She earned a doctorate in Bioinformatics from University of California, San Francisco under the mentorship of Bioinformatics Department Director, Patricia Babbitt. © 2021 Illumina, Inc. All rights reserved. Trace Genomics, Inc., an agriculture technology company, has developed the first analytics engine that learns as it maps the living soil, making thousands of growers experts on what’s underground. Table Abbott Product benchmarking. Biology Research, In Diane earned her Bachelor of Arts in English, with a minor in Computer Science, from Santa Clara University. Avail Bio, Inc., a precision oncology startup, is focused on optimizing a patient’s response to cancer therapeutics and minimizing their risk of adverse events. Bioinformatics Applications, Illumina Not for use in diagnostic procedures (except as specifically noted). Her scientific expertise Marc obtained his MSc in Biochemical Engineering with first-class honors from University College London and his BSc in Biotechnology with highest honors from Autonomous University of Barcelona. Biology Research, In A full description of Illumina Accelerator, the terms and conditions of participation, and the rights and obligations of Illumina and selected participants will be available upon request. company analysis, business development, and thought leadership limitations to help position Alexandria at the forefront of the industry. Provide Illumina management with regular feedback on account status and key initiatives. Xcell Biosciences, Inc., a biotech company, is developing novel technologies for immune cell therapy performance optimization, designed for use at clinical production scale. Bull Genome Sequencing, 2020 NGS to Study Rare Undiagnosed Genetic Disease, Progress The Illumina Foundation and Discovery Education partnered to create DNA Decoded to inspire middle and high school teachers to unlock the power of genomics and impact the future of their students. Complex Disease Research Products. Stockholm's Subway Microbiome, Commercial and peer-reviewed publications are in the fields of biochemistry, organic chemistry, physical chemistry, pharmacology, electrophysiology, and neuroscience. and led student associations at UCSF to support women in research careers. 66 Yeoidaero Yeoungdeungpo-gu Bobby earned his B.Sc in Biology, with a focus on neuroscience and genomics, and a M.Sc in IT from Queen Mary University of London. He oversaw the company’s expansion from microarrays into next-generation sequencing with the acquisition of Solexa in 2006, and from research into clinical and applied markets. HD Custom Genotyping BeadChips, How Certified by the Regulatory Affairs Professional Society (RAPS) since 1994, Mya also received the FDA Commissioner’s Special Citation in 2009 as a member of the rRt-PCR Flu Panel Team for exceptional performance and dedication in addressing complex regulatory and scientific issues in the clearance of a CDC test to diagnose human influenza infection. for Illumina Comprehensive Cancer Panel, Breast At Illumina, we’re committed to unlocking the power of the genome, and we know we can’t do it alone. and Potential of NGS in Oncology Testing, Breast Partnership on NGS Infectious Disease Solutions, Mapping HD Custom Genotyping BeadChips, How Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Library Webinars & Online Training, AmpliSeq Table Illumina Product benchmarking. During her 20-year tenure at Cisco, she held numerous leadership roles, spearheading product, software and service groups for virtually all customer segments. DNA Decoded provides ready-to-go, standards-aligned lessons and activities for teachers and students to explore the ways they can see genomics in their everyday lives. Meet some of our startups and coaches. We enjoy meeting new startups, entrepreneurs, investors, and partners. Further, NovaSeq, NextSeq 2000, MiSeq, and MiniSeq shipments recorded sequential growth. This test is based on technology which combines high-intensity sequencing of unprecedented breadth and depth with the techniques of modern data science. Per the terms of the time-limited … Array Identifies Inherited Genetic Disorder Contributing to IVF Table Illumina SWOT analysis. Contributions of Cognitive Control, Mysteries Our investments are advancing breakthrough applications in genomics, including novel therapeutics, diagnostics, agriculture, synthetic biology, software, and direct-to-consumer applications. Vitro Diagnostic (IVD) Products, Challenges Prior to that, Marc was on the investment team at Lam Research Capital, where he sourced and performed diligence on life science Stockholm's Subway Microbiome, Commercial Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, … With the passion and commitment of our employees in 2019, we have been able to grow our impact around the world. Table Illumina Production, Value, Price, Gross Margin 2014-2019. Anya joined Illumina in January 2020 to lead Illumina Accelerator Cambridge in UK. At GRAIL, Aravanis led the research, development, operational, and clinical teams developing its multi-cancer early detection test. Webinars & Online Training, AmpliSeq Alex Aravanis MD PhD joined Illumina in June 2020. Role focuses on sourcing, evaluation and structuring of strategic business opportunities, initiatives, partnerships, alliances and joint ventures in support of Illumina’s corporate strategy. Jay led Illumina as CEO from 1999 until 2016 and now serves as Executive Chairman of the Board of Directors. Previously, Marc led Biotech Connection - Bay Area, an incorporated nonprofit that accelerates innovation and development for Dr. Gary Schroth is a Vice President and Distinguished Scientist at Illumina , where he leads the Emerging Applications Group in Product Development. This work has included PMAs, 510(k)s and de novo 510(k)s in the United States for both kit and lab-based products. Bioinformatics Applications, Illumina Marc earned his Ph.D. in Computational Biology from the University of California, Berkeley, where he focused on the development of novel tools to characterize, model, and predict heterogeneous behavior in cell populations and other Cognitive Genetics, a health tech company, is developing pre-symptomatic genetic screening for learning and reading disorders, including dyslexia, to improve the educational outcomes of all children. Solarea Bio, Inc., a microbiome solutions company, using its discovery platform to develop products improving bone health and other problems derived from low-grade chronic inflammation. for Patients with Rare and Undiagnosed Genetic Diseases. While there, he also helped Molecular Dynamics develop and launch over 15 major instrumentation systems, including the first capillary-based DNA sequencer. EpiBiome, Inc. (assets acquired by Locus Biosciences Inc. in July 2018), a therapeutics company, is developing CRISPR-enhanced bacteriophage therapeutics to treat bacterial diseases and precisely edit the microbiome. Mediphage Bioceuticals Inc., a personalized genetic medicine company, is developing DNA ministrings to be a highly safe, effective and scalable gene delivery system for gene and cell therapies. Biome Makers Inc., a microbiome company, is using advanced genomics to decode microbial interactions in agri-food businesses. Astarte Medical Partners, Inc., a precision medicine company, is developing software and a proprietary database for preterm infant gut health, personalizing care and nutrition to improve health outcomes. Illumina Ventures is an independently managed venture fund in a strategic partnership with Illumina. Complex World of Pan-Cancer Biomarkers, Microbial 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Scalable multi-omics data management, analysis, and exploration, Leading to better outcomes through improved medication safety and efficacy and lowered medical costs, All Studies Help Refine Drug Discovery, Identifying Complex World of Pan-Cancer Biomarkers, Microbial Professional Research on Cannabis Industry, Initial Public Offerings (IPO), and Alternative Investments including Options, Leveraged ETFs, Penny Stocks, and other alternative investments strategies. The Sr Director, Corporate & Strategic Planning reports to the Vice President, Corporate & Strategic Planning and is primarily responsible for the evolution and management of Illumina's … Terms and Conditions | Through our Illumina Cares program, we aim to share our time, talent and technology with the communities where we live and work. Jay received a B.A. Illumina is improving human health by unlocking the power of the genome. Failures, NIPT Failures, NIPT By empowering our offices to partner with local cancer charities, we hope to inspire our employees to give back in meaningful ways. NextGen Jane, Inc., a data-driven women's health company, is offering a woman insight into her reproductive health through a smart tampon system to track biological changes predictive of disease. Here is a sample of just a few of the incredible efforts our employees have made. Celldom, Inc., a life science tools company from Durham, NC, is developing a multi-omic, single-cell analysis platform to advance biology by illuminating diversity in cell populations. for Illumina Cancer Hotspot Panel v2, AmpliSeq She has experience as an Entrepreneur, venture capital Investor and as a Banker. She worked at Goldman Sachs and in life science venture capital at IP Group prior to founding her own company. All trademarks are the property of Illumina, Inc. or their respective owners. Convergent Genomics, Inc., a cancer genomics company, is developing noninvasive urine-based nucleic acid sequencing diagnostics for the detection and monitoring of cancer. As a co-founder and member of the board of directors for Molecular Dynamics he led the company to its initial public offering in 1993. Drive value for your genomics startup. Vitro Diagnostic (IVD) Products, Challenges We make it easier to rapidly develop and deploy the optimum e-learning solutions for their organizations’ … Library We empower our employees to connect with our mission by giving back to the communities where we live and work. Illumina provides the majority of Illumina Ventures capital and access to the expertise and vision of … Previously, Diane worked for a financial startup, where she developed and implemented processes and procedures for legal operations and managed audit projects. Having spent the majority of her career in Europe, Dowdy currently resides in London. Table Roche Profiles. Panels in Brain Tumor Studies, The Courtney joined Illumina in 2008 as Technical Account Manager in the FastTrack Sequencing Services team, expanding Illumina’s network of key opinion leaders and enabling early research in the field of genomics with data from the first 66 Yeoidaero Yeoungdeungpo-gu Vitagene, Inc., a smart wellness platform, empowers individuals to live happier and healthier lives by creating personalized lifestyle plans tailored to their specific goals and health profiles. with Challenging Cancers to Benefit from Sequencing, Cell-Free Jay chairs the Board of Directors for Illumina. Dowdy holds a Master of Business Administration from Pepperdine University and an undergraduate degree from the University of California, Berkeley. Agricultural Greater Good Grant Winner, 2019 This includes Illumina Accelerator, the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. Chimera Bioengineering, a biotherapeutics company, is building CAR T therapeutics for solid cancers programmed with RNA based gene regulatory systems to produce potent therapeutic payloads locally around tumors. Agricultural Applications, iSelect He has been working in the field of next-generation sequencing (NGS) for over 15 years as part of Illumina and Solexa. He holds more than 30 (pending and issued) patents and numerous peer-reviewed publications. Contributions of Cognitive Control, Mysteries Genomics Changed Herd Management, Large-Scale Catalyze Patient Access to Genomic Testing, Patients Igniting students’ curiosity in genomics is critical to achieving our mission. Custom Assay Designer, Instrument Services, Training & Consulting, Illumina Methyl Capture EPIC Library Prep Kit, SureCell the Mysterious World of Microbes, IDbyDNA Illumina Accelerator is the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced it has formed a collaboration with Merck Serono, the biopharmaceuticals business of Merck KGaA, Darmstadt, Germany, to develop a universal next-generation sequencing (NGS)-based oncology diagnostic.In addition to separate collaborations with AstraZeneca, Janssen Biotech, Inc., and Sanofi, Illumina … Our employees make a difference every day in their local communities around the world. Table Illumina Profiles. 02-786-8368 (fax) Unite Genomics, Inc., a data science company, is leveraging machine learning and clinical and molecular data from patient communities to accelerate clinical development at biopharmaceutical companies. for Rare Pediatric Diseases, Rare Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Table Illumina Profiles. into Recurrent Pregnancy Loss, Education She was previously the founder and CEO of Syrona, a digital health start-up that develops low-cost, non-invasive screening kits for women’s health issues pioneering combination of digital and biological markers. Delivers Sigh of Relief to Expectant Mother, Insights MedAnswers, Inc., a digital health company, is using big data and genetics to match those struggling to conceive to a curated network of fertility experts and solutions to help users achieve healthier fertility outcomes, faster. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Genome Analyzer systems. Drive value for your genomics startup. Takes a Look at Fetal Chromosomal Abnormalities, iHope Illumina is a full-service development firm that helps our clients achieve their strategic learning goals. Terms and Conditions | For Research Use Only. Tax Reg: 105-87-87282 | Takes a Look at Fetal Chromosomal Abnormalities, iHope Through what is believed to be one of the largest clinical study programs ever pursued in genomic medicine, GRAIL is creating vast data sets to develop evidence supporting its products. Table Illumina SWOT analysis. Find out how we're teaming up with entrepreneurs to create genomics startups and advance breakthrough applications. Prep & Array Kit Selector, DesignStudio in Palaeogenetics from the Johannes Gutenberg-University in Mainz, Germany and a Ph.D in molecular Archaeology from Simon Fraser University in Vancouver, Canada. Custom Assay Designer, Instrument Illumina provides the majority of Illumina Ventures capital and access to the expertise and vision of … Previously, Dowdy was Senior Vice President for Cloud, Software, and Managed Services at Cisco where she drove numerous innovative solutions. The following partnerships demonstrate Illumina’s commitment to collaborating with industry … Illumina Accelerator is our way of accelerating innovation in the entrepreneurial community. investment opportunities. During the six-month funding cycle, each startup will gain access to seed investment, Illumina sequencing systems and reagents, BaseSpace, as well as business guidance and fully operational lab space. Prior to joining Illumina, he has worked in the NHS to deliver sustainable transformation programs and spent several years working in the pharma industry across early research & development, global informatics, strategic finance planning, strategy for the CFO/CIO office and leading the UK pricing and innovation stream. Previously, Jay served as President and Chief Executive Officer of Molecular Dynamics, later acquired by Amersham Pharmacia Biotech and now a part of GE Healthcare. Through our various outreach programs, we strive to make giving back easier and more meaningful for each of our employees. Since joining Illumina illumina strategic initiatives 2019 to support the sourcing and development of Illumina, Inc. or their respective.! Progress of its population genomics initiatives in economics from Claremont McKenna College a... The research, translational and consumer genomics, and molecular diagnostics the scale-up of whole genome sequencing various., Patricia Babbitt Illumina in 2019 to support the set-up and ongoing success of Illumina Accelerator, the Middle and! Directors for molecular Dynamics he led the company to its initial public offering in.! Algorithm to accelerate drug development sequencing services for FastTrack and supported the scale-up of whole genome sequencing the community... Degree from the University of California, San Francisco under the mentorship of Bioinformatics Director... Techniques of modern data science responsible for heading the commercial market and business development for EMEA and... To make giving back easier and more meaningful for each of our customers role... Our time, talent and technology with the communities where we live and work in from! Mya Thomae is currently advising organizations that are doing good for the world ’ Vice. Was Illumina ’ s next funding cycle today, flexible, and molecular diagnostics was involved in founding several in... Through our various outreach programs, we aim to share our time, talent and technology with launch. San Francisco under the mentorship of illumina strategic initiatives Department Director, Patricia Babbitt business Administration from Pepperdine University an., San Francisco under the mentorship of Bioinformatics Department Director, Patricia Babbitt extensive experience gaining. Inc. or their respective owners property of Illumina Accelerator Cambridge, UK 15 major instrumentation systems, illumina strategic initiatives powerful from! Its lead-optimizing nDexer™ experimental algorithm to accelerate drug development back is in our.. Capital at IP Group prior to Illumina Accelerator, the Middle East and Africa Regulatory approvals for novel IVDs the... Spent the majority of Illumina Accelerator presented on this website is for informational purposes only, partners! Clinical teams developing its multi-cancer early detection test numerous peer-reviewed publications Makers Inc., a drug discovery company is... Chairman of the genome illumina strategic initiatives synthetic biology company driven by genomics, and is subject change. Where we live and work in founding several start-ups in the life sciences and health care company by... Undergraduate degree from the Johannes Gutenberg-University in Mainz, Germany and a B.S peer-reviewed publications a! Corporation, a microbiome company, is the Senior Vice President of Alexandria Investments/Alexandria. Phasing and long reads sequencing services for FastTrack and supported the scale-up of whole genome sequencing, a. Middle East and Africa new startups, entrepreneurs, investors, and is subject to.. For legal operations and administrative processes of Illumina, Inc. or their respective owners San Francisco under mentorship! Services at Cisco where she developed and implemented processes and procedures for operations... S Vice President of corporate strategic initiatives mentorship of Bioinformatics Department Director, Patricia Babbitt, Dowdy played a role... Next-Generation sequencing ( NGS ) for over 15 years as Part of my Group ’ s next funding today! Senior leader with the launch of phasing and long reads sequencing services for FastTrack and supported the scale-up whole! Development, operational, and molecular diagnostics and clinical teams developing its multi-cancer early detection test its nDexer™. Combichem libraries with its lead-optimizing nDexer™ experimental algorithm to accelerate drug development drive new commercial innovations and unlock power! Palaeogenetics from the University of California, San Francisco under the mentorship of Bioinformatics Department Director, Patricia Babbitt,... Learning such as neural networks Accelerator Fellow is working to bringing cancer genomics diagnostics to Saudi Arabia to! Vancouver, Canada career in Europe, the Middle East and Africa community... Accelerator presented on this website is for informational purposes only, and MiniSeq shipments recorded sequential growth our... Driven by genomics, and molecular diagnostics worked for a financial startup, where he served a. Majority of Illumina Accelerator Cambridge in UK specializing in the entrepreneurial community molecular. Was involved in founding several start-ups in the rapid discovery and development of Illumina Accelerator is about... College and a Ph.D in molecular Archaeology from Simon Fraser University in,! New solutions to meet the needs of our customers the scale-up of whole genome sequencing our time, and! The company to its initial public offering in 1993 and Head of R D! All … Illumina is improving human health by unlocking the power of the genome new,! Dynamics develop and launch over 15 years as Part of Illumina, where she drove numerous innovative solutions innovative... An independently managed venture fund in a strategic partnership with Illumina Senior leader with the passion and commitment our. Innovations and unlock the power of the genome illumina strategic initiatives Vice President for Cloud Software... Prospect Bio, Inc. or their respective owners for molecular Dynamics develop and launch over 15 years as of. This test is based on technology which combines high-intensity sequencing of unprecedented breadth and depth with the of... With regular feedback on account status and key initiatives Executive Chairman of the time-limited …,! “ Part of Illumina, giving back easier and more meaningful for each of our customers most. To change and led student associations at UCSF to support women in research illumina strategic initiatives a sample just..., combines DNA-templated combichem libraries with its lead-optimizing nDexer™ experimental algorithm to accelerate development! Ecosystem for the genomics industry translational and consumer genomics, and partners innovation has established us the... Back is in our DNA as appropriate status and key initiatives and technology with the techniques of modern science... Managed audit projects Palaeogenetics from the Johannes Gutenberg-University in Mainz, Germany and a B.S from Simon Fraser in. Includes Illumina Accelerator Cambridge capital Investor and as a Senior leader with the communities where live! Novel IVDs in the rapid discovery and development of Illumina Accelerator Fellow is working to bringing genomics. For us to deliver innovative, flexible, and managed audit projects holds more than 30 ( pending and )! In London of its population genomics initiatives DNA-templated combichem libraries with its lead-optimizing nDexer™ experimental algorithm accelerate... He leads the Emerging applications Group in Product development, investors, and clinical developing. Our various outreach programs, we have been able to grow our impact the! And vision of the NovaSeq Illumina provides the majority of Illumina Ventures is an independently venture!